John Stephen Kellogg, MD
Allergy/Immunology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 6 carriers
- Office
- 1
Offices
1 location · South Bay Allergy and Asthma Group Inc · 4 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
21 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kellogg’s office at (408) 286-1707 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A54166 · Current
Licensed to practise in California · since 1995 · expires 2027-05-31 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$80,176
Medicare paid this office $80,176 for 169 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 95 | $19,340 | $112 |
| Professional service for preparation and provision of 1 or more antigens | 50 | $17,359 | $15 |
| Short return visit (20+ min) | 72 | $8,343 | $81 |
| Professional service for multiple injections of allergen | 53 | $8,099 | $12 |
| New patient visit (45+ min) | 50 | $7,444 | $149 |
See all 10 services
| Return visit (30+ min) | 95 | $19,340 | $112 |
| Professional service for preparation and provision of 1 or more antigens | 50 | $17,359 | $15 |
| Short return visit (20+ min) | 72 | $8,343 | $81 |
| Professional service for multiple injections of allergen | 53 | $8,099 | $12 |
| New patient visit (45+ min) | 50 | $7,444 | $149 |
| Test for allergy using allergenic extract | 28 | $3,614 | $3 |
| Test to measure the level of nitric oxide gas | 78 | $3,408 | $20 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 38 | $2,436 | $37 |
| Test to measure expiratory airflow and volume | 50 | $1,974 | $28 |
| Test for allergy using allergenic extract injected into skin | 20 | $955 | $9 |
Who their Medicare patients are
169 Original Medicare patients in 2024. Average age 75 · Women 63% · Also on Medicaid 9% · Health risk score 0.92. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 66% · Diabetes 28% · Coronary heart disease 27% · Depression 17% · Cancer 15% · Chronic kidney disease 13% · COPD 13% · Atrial fibrillation 9% · Heart failure 8% · Stroke 7%.
The office billed $326,959, Medicare allowed $107,528 and paid $80,176; for 4,505 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 169 | 4,505 | 75 | 0.92 | $326,959 | $80,176 |
| 2023 | 148 | 5,051 | 74 | 0.87 | $308,850 | $79,946 |
| 2022 | 153 | 5,002 | 75 | 0.95 | $321,425 | $85,260 |
| 2021 | 142 | 3,710 | 74 | 1.03 | $272,907 | $76,955 |
| 2020 | 121 | 3,339 | 73 | 0.98 | $210,471 | $56,867 |
| 2019 | 148 | 5,078 | 73 | 1.00 | $312,879 | $91,190 |
| 2018 | 169 | 4,729 | 75 | 1.05 | $292,145 | $85,140 |
| 2017 | 112 | 2,779 | 75 | 1.02 | $166,513 | $47,308 |
| 2016 | 109 | 2,935 | 73 | 1.08 | $164,600 | $45,960 |
| 2015 | 99 | 2,870 | 72 | 0.85 | $159,961 | $45,514 |
| 2014 | 99 | 2,463 | 71 | 1.01 | $123,857 | $41,252 |
| 2013 | 94 | 1,583 | 72 | 0.88 | $85,408 | $30,027 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Professional service for preparation and provision of 1 or more antigens | 46 | $16,417 | $15 |
| Return visit (30+ min) | 83 | $15,422 | $113 |
| Short return visit (20+ min) | 95 | $11,901 | $82 |
| Professional service for multiple injections of allergen | 44 | $8,353 | $12 |
| Test for allergy using skin patch | 15 | $6,270 | $5 |
| New patient visit (45+ min) | 40 | $6,138 | $153 |
| Test for allergy using allergenic extract | 34 | $5,541 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $1,303 | $37 |
| Test for allergy using allergenic extract injected into skin | 21 | $1,253 | $9 |
| Test to measure the level of nitric oxide gas | 41 | $1,172 | $20 |
| Test to measure expiratory airflow and volume | 15 | $420 | $28 |
2022: 9 services
| Professional service for preparation and provision of 1 or more antigens | 43 | $26,939 | $15 |
| Return visit (30+ min) | 92 | $22,711 | $114 |
| Professional service for multiple injections of allergen | 42 | $8,569 | $12 |
| Short return visit (20+ min) | 59 | $6,902 | $78 |
| New patient visit (45+ min) | 44 | $6,692 | $152 |
| Test for allergy using allergenic extract | 27 | $4,832 | $4 |
| Test for allergy using allergenic extract injected into skin | 19 | $1,211 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $1,152 | $40 |
| Test to measure the level of nitric oxide gas | 35 | $963 | $20 |
2021: 9 services
| Return visit (30+ min) | 91 | $21,572 | $121 |
| Professional service for preparation and provision of 1 or more antigens | 38 | $20,727 | $16 |
| New patient visit (45+ min) | 45 | $6,850 | $152 |
| Short return visit (20+ min) | 54 | $6,463 | $84 |
| Professional service for multiple injections of allergen | 36 | $6,116 | $12 |
| Test for allergy using allergenic extract | 22 | $4,344 | $4 |
| Test to measure the level of nitric oxide gas | 33 | $937 | $22 |
| Test for allergy using allergenic extract injected into skin | 12 | $837 | $9 |
| Test to measure expiratory airflow and volume | 17 | $595 | $31 |
2020: 8 services
| Return visit (30+ min) | 90 | $17,904 | $99 |
| Professional service for preparation and provision of 1 or more antigens | 44 | $16,722 | $14 |
| Professional service for multiple injections of allergen | 40 | $5,148 | $11 |
| New patient visit (45+ min) | 20 | $3,132 | $157 |
| Short return visit (20+ min) | 26 | $2,820 | $69 |
| Test for allergy using allergenic extract | 14 | $2,694 | $4 |
| Test to measure expiratory airflow and volume | 31 | $1,150 | $33 |
| Test to measure the level of nitric oxide gas | 27 | $642 | $19 |
2019: 10 services
| Return visit (30+ min) | 116 | $28,561 | $96 |
| Professional service for preparation and provision of 1 or more antigens | 54 | $25,893 | $14 |
| Professional service for multiple injections of allergen | 48 | $7,571 | $11 |
| Test to measure expiratory airflow and volume | 85 | $6,321 | $34 |
| Test for allergy using allergenic extract | 22 | $4,641 | $4 |
| New patient visit (45+ min) | 30 | $4,382 | $146 |
| Test to measure the level of nitric oxide gas | 80 | $3,759 | $20 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $1,621 | $54 |
| Professional service for single injection of allergen | 15 | $1,334 | $9 |
| Short return visit (20+ min) | 12 | $955 | $64 |
2018: 11 services
| Professional service for preparation and provision of 1 or more antigens | 58 | $20,526 | $13 |
| Return visit (30+ min) | 90 | $20,305 | $96 |
| Short return visit (20+ min) | 96 | $9,790 | $63 |
| Professional service for multiple injections of allergen | 49 | $6,505 | $10 |
| Test to measure expiratory airflow and volume | 81 | $5,568 | $35 |
| Test for allergy using allergenic extract | 22 | $5,371 | $5 |
| New patient visit (45+ min) | 40 | $5,333 | $133 |
| Test to measure the level of nitric oxide gas | 61 | $2,509 | $19 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | $2,274 | $57 |
| Professional service for single injection of allergen | 17 | $1,391 | $9 |
| Test for allergy using allergenic extract injected into skin | 15 | $1,079 | $8 |
2017: 9 services
| Short return visit (20+ min) | 95 | $16,270 | $62 |
| Professional service for preparation and provision of 1 or more antigens | 25 | $10,432 | $12 |
| Test for allergy using allergenic extract | 13 | $4,132 | $6 |
| Test to measure expiratory airflow and volume | 60 | $3,987 | $34 |
| Professional service for multiple injections of allergen | 21 | $3,232 | $9 |
| New patient visit (45+ min) | 19 | $2,662 | $140 |
| Return visit (30+ min) | 15 | $1,604 | $94 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $1,054 | $59 |
| Test to measure the level of nitric oxide gas | 35 | $1,038 | $19 |
2016: 6 services
| Short return visit (20+ min) | 94 | $17,028 | $62 |
| Professional service for preparation and provision of 1 or more antigens | 23 | $10,227 | $12 |
| Test for allergy using allergenic extract | 22 | $5,531 | $7 |
| New patient visit (45+ min) | 31 | $4,618 | $149 |
| Professional service for multiple injections of allergen | 19 | $3,256 | $9 |
| Return visit (30+ min) | 11 | $888 | $81 |
2015: 5 services
| Short return visit (20+ min) | 89 | $17,598 | $64 |
| Professional service for preparation and provision of 1 or more antigens | 21 | $7,785 | $12 |
| Test for allergy using allergenic extract | 23 | $5,364 | $6 |
| New patient visit (45+ min) | 33 | $4,718 | $143 |
| Professional service for multiple injections of allergen | 17 | $3,067 | $10 |
2014: 6 services
| Short return visit (20+ min) | 81 | $14,061 | $64 |
| Professional service for preparation and provision of 1 or more antigens | 19 | $7,552 | $11 |
| Test for allergy using allergenic extract | 27 | $5,516 | $6 |
| New patient visit (45+ min) | 38 | $5,453 | $143 |
| Professional service for multiple injections of allergen | 15 | $2,560 | $10 |
| Test to measure expiratory airflow and volume | 17 | $1,043 | $35 |
2013: 7 services
| Short return visit (20+ min) | 78 | $12,481 | $63 |
| Test for allergy using allergenic extract | 17 | $3,810 | $7 |
| Professional service for preparation and provision of 1 or more antigens | 14 | $2,964 | $13 |
| New patient visit (45+ min) | 21 | $2,937 | $140 |
| Professional service for multiple injections of allergen | 12 | $1,868 | $10 |
| Test to measure expiratory airflow and volume | 16 | $1,136 | $36 |
| Inhalation treatment for airway obstruction or sputum production | 20 | $545 | $19 |
Drugs they prescribed that Part D paid
$712,493
Pharmacies billed $712,493 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 539) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
296 generic and 243 brand-name prescriptions · $712,493 in drug cost · 31 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 24 | $87,918 | $3,663 |
| Nucala | 13 | $55,657 | $4,281 |
| Tezspire | 11 | $40,490 | $3,681 |
| Trelegy Ellipta | 38 | $28,760 | $757 |
| Alvesco | 12 | $10,948 | $912 |
See all 19 drugs
| Dupixent | 24 | $87,918 | $3,663 |
| Nucala | 13 | $55,657 | $4,281 |
| Tezspire | 11 | $40,490 | $3,681 |
| Trelegy Ellipta | 38 | $28,760 | $757 |
| Alvesco | 12 | $10,948 | $912 |
| Breo Ellipta | 11 | $8,466 | $770 |
| Ryaltris | 12 | $3,904 | $325 |
| Qvar Redihaler | 14 | $3,521 | $252 |
| Omnaris | 11 | $3,155 | $287 |
| Ipratropium | 61 | $2,467 | $40 |
| Azelastine-Fluticasone | 15 | $1,887 | $126 |
| Azelastine | 30 | $1,465 | $49 |
| Ventolin Hfa | 16 | $1,007 | $63 |
| Albuterol Sulfate Hfa | 24 | $648 | $27 |
| Montelukast | 44 | $642 | $15 |
| Fluticasone Propionate | 12 | $338 | $28 |
| Azithromycin | 21 | $163 | $8 |
| Prednisone | 15 | $55 | $4 |
| Triamcinolone Acetonide | 13 | $37 | $3 |
Year by year
| 2024 | 539 | 107 | 0% (0) | 45% | $712,493 |
| 2023 | 407 | 90 | 0% (0) | 41% | $174,074 |
| 2022 | 427 | 101 | 0% (0) | 31% | $151,828 |
| 2021 | 528 | 93 | 0% (0) | 42% | $182,019 |
| 2020 | 548 | 83 | 0% (0) | 49% | $200,324 |
| 2019 | 594 | 104 | 0% (0) | 42% | $165,577 |
| 2018 | 773 | 126 | 0% (0) | None | $197,892 |
| 2017 | 627 | 85 | 0% (0) | 49% | $146,697 |
| 2016 | 504 | 79 | 0% (0) | 45% | $74,806 |
| 2015 | 404 | 61 | 0% (0) | 35% | $38,205 |
| 2014 | 253 | 48 | 0% (0) | 46% | $32,514 |
| 2013 | 125 | 33 | 0% (0) | 59% | $21,105 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Dupixent | 19 | $64,527 | $3,396 |
| Breo Ellipta | 25 | $20,485 | $819 |
| Trelegy Ellipta | 16 | $15,297 | $956 |
| Breztri Aerosphere | 13 | $10,662 | $820 |
| Azelastine | 44 | $2,456 | $56 |
| Azelastine-Fluticasone | 14 | $2,350 | $168 |
| Ipratropium | 42 | $2,161 | $51 |
| Fluticasone Propionate | 18 | $799 | $44 |
| Albuterol Sulfate Hfa | 24 | $792 | $33 |
| Montelukast | 38 | $768 | $20 |
| Azithromycin | 14 | $71 | $5 |
| Triamcinolone Acetonide | 13 | $68 | $5 |
| Prednisone | 12 | $43 | $4 |
2022: 11 drugs
| Dupixent | 17 | $54,046 | $3,179 |
| Breo Ellipta | 20 | $13,705 | $685 |
| Azelastine | 82 | $3,897 | $48 |
| Azelastine-Fluticasone | 19 | $3,339 | $176 |
| Arnuity Ellipta | 11 | $3,071 | $279 |
| Ipratropium | 36 | $2,180 | $61 |
| Albuterol Sulfate Hfa | 27 | $1,095 | $41 |
| Fluticasone Propionate | 23 | $969 | $42 |
| Montelukast | 47 | $799 | $17 |
| Prednisone | 14 | $84 | $6 |
| Azithromycin | 11 | $37 | $3 |
2021: 15 drugs
| Nucala | 12 | $41,150 | $3,429 |
| Dupixent | 13 | $38,519 | $2,963 |
| Trelegy Ellipta | 30 | $20,367 | $679 |
| Breo Ellipta | 27 | $16,346 | $605 |
| Symbicort | 22 | $13,452 | $611 |
| Arnuity Ellipta | 20 | $6,860 | $343 |
| Azelastine | 101 | $5,009 | $50 |
| Azelastine-Fluticasone | 25 | $4,599 | $184 |
| Ipratropium | 42 | $2,964 | $71 |
| Albuterol Sulfate Hfa | 28 | $1,372 | $49 |
| Montelukast | 51 | $1,062 | $21 |
| Fluticasone Propionate | 44 | $984 | $22 |
| Levalbuterol Tartrate Hfa | 14 | $738 | $53 |
| Azithromycin | 13 | $100 | $8 |
| Prednisone | 11 | $63 | $6 |
2020: 13 drugs
| Dupixent | 18 | $57,800 | $3,211 |
| Breo Ellipta | 52 | $27,906 | $537 |
| Symbicort | 13 | $10,546 | $811 |
| Spiriva Respimat | 11 | $4,951 | $450 |
| Dulera | 11 | $3,389 | $308 |
| Arnuity Ellipta | 13 | $2,937 | $226 |
| Azelastine | 51 | $2,471 | $48 |
| Ventolin Hfa | 26 | $1,732 | $67 |
| Ipratropium | 32 | $1,437 | $45 |
| Fluticasone Propionate | 50 | $1,238 | $25 |
| Albuterol Sulfate Hfa | 24 | $1,177 | $49 |
| Montelukast | 63 | $1,106 | $18 |
| Prednisone | 16 | $68 | $4 |
2019: 13 drugs
| Breo Ellipta | 44 | $22,993 | $523 |
| Advair Diskus | 21 | $16,686 | $795 |
| Symbicort | 11 | $8,774 | $798 |
| Spiriva Respimat | 18 | $7,688 | $427 |
| Dymista | 22 | $5,344 | $243 |
| Azelastine | 66 | $2,862 | $43 |
| Ipratropium | 38 | $2,010 | $53 |
| Ventolin Hfa | 22 | $1,491 | $68 |
| Fluticasone Propionate | 61 | $1,189 | $19 |
| Montelukast | 64 | $1,066 | $17 |
| Nystatin | 16 | $419 | $26 |
| Prednisone | 24 | $129 | $5 |
| Azithromycin | 17 | $112 | $7 |
2018: 18 drugs
| Nucala | 12 | $63,882 | $5,324 |
| Breo Ellipta | 49 | $23,955 | $489 |
| Advair Diskus | 26 | $16,247 | $625 |
| Alvesco | 26 | $11,672 | $449 |
| Spiriva Respimat | 21 | $9,104 | $434 |
| Latuda | 25 | $7,634 | $305 |
| Azelastine | 90 | $4,158 | $46 |
| Dymista | 19 | $3,896 | $205 |
| Ventolin Hfa | 42 | $2,594 | $62 |
| Ipratropium | 51 | $1,752 | $34 |
| Olopatadine | 16 | $1,714 | $107 |
| Fluticasone Propionate | 66 | $1,072 | $16 |
| Montelukast | 51 | $869 | $17 |
| Proair Hfa | 13 | $789 | $61 |
| Azithromycin | 40 | $232 | $6 |
| Prednisone | 47 | $211 | $4 |
| Donepezil | 12 | $139 | $12 |
| Amoxicillin-Clavulanate Potass | 11 | $117 | $11 |
2017: 22 drugs
| Advair Diskus | 39 | $19,594 | $502 |
| Breo Ellipta | 46 | $16,614 | $361 |
| Spiriva Respimat | 19 | $7,075 | $372 |
| Advair Hfa | 14 | $6,985 | $499 |
| Alvesco | 14 | $6,469 | $462 |
| Dymista | 15 | $5,289 | $353 |
| Latuda | 18 | $5,010 | $278 |
| Zetonna | 14 | $3,308 | $236 |
| Azelastine | 38 | $2,356 | $62 |
| Olopatadine | 11 | $1,765 | $160 |
| Divalproex Sodium Er | 12 | $1,147 | $96 |
| Proair Hfa | 18 | $1,084 | $60 |
| Ventolin Hfa | 13 | $837 | $64 |
| Ipratropium | 17 | $812 | $48 |
| Xopenex Hfa | 11 | $761 | $69 |
| Montelukast | 52 | $730 | $14 |
| Fluticasone Propionate | 48 | $567 | $12 |
| Omeprazole | 14 | $355 | $25 |
| Nystatin | 14 | $346 | $25 |
| Azithromycin | 27 | $235 | $9 |
| Prednisone | 32 | $166 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $106 | $10 |
2016: 14 drugs
| Breo Ellipta | 31 | $9,267 | $299 |
| Alvesco | 11 | $8,601 | $782 |
| Spiriva | 20 | $6,716 | $336 |
| Advair Diskus | 18 | $6,657 | $370 |
| Dymista | 17 | $4,972 | $292 |
| Zetonna | 14 | $3,269 | $233 |
| Azelastine | 32 | $1,209 | $38 |
| Proair Hfa | 18 | $973 | $54 |
| Montelukast | 37 | $843 | $23 |
| Ipratropium | 36 | $786 | $22 |
| Fluticasone Propionate | 51 | $565 | $11 |
| Omeprazole | 14 | $371 | $27 |
| Azithromycin | 43 | $301 | $7 |
| Prednisone | 27 | $194 | $7 |
2015: 12 drugs
| Alvesco | 13 | $5,369 | $413 |
| Zetonna | 16 | $3,030 | $189 |
| Qvar | 13 | $2,346 | $180 |
| Azelastine | 24 | $901 | $38 |
| Ipratropium | 42 | $896 | $21 |
| Proair Hfa | 13 | $711 | $55 |
| Montelukast | 36 | $351 | $10 |
| Omeprazole | 20 | $330 | $16 |
| Fluticasone Propionate | 37 | $305 | $8 |
| Prednisone | 37 | $231 | $6 |
| Azithromycin | 19 | $123 | $6 |
| Nystatin | 11 | $93 | $8 |
2014: 8 drugs
| Alvesco | 14 | $6,779 | $484 |
| Symbicort | 12 | $2,754 | $229 |
| Amoxicillin-Clavulanate Er | 13 | $1,818 | $140 |
| Zetonna | 11 | $1,738 | $158 |
| Ipratropium | 20 | $406 | $20 |
| Prednisone | 34 | $237 | $7 |
| Fluticasone Propionate | 15 | $212 | $14 |
| Montelukast | 11 | $134 | $12 |
2013: 1 drug
| Qvar | 13 | $1,932 | $149 |
Money from drug and device companies
$4,087 in 2025
| 2025 | 24 | 182 | None | $4,087 |
| 2024 | 22 | 105 | None | $2,159 |
| 2023 | 18 | 114 | None | $2,809 |
| 2022 | 22 | 130 | None | $2,366 |
| 2021 | 24 | 119 | None | $2,118 |
| 2020 | 17 | 99 | None | $1,735 |
| 2019 | 22 | 78 | None | $1,698 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $715 | 15 payments
|
| GlaxoSmithKline | Nucala | $709 | 32 payments
|
| Genzyme | Dupixent | $412 | 15 payments
|
| CSL Behring | Andembry | $314 | 12 payments
|
| ARS Pharmaceuticals Operations | Neffy | $246 | 23 payments
|
| Regeneron Healthcare Solutions | Dupixent | $230 | 8 payments
|
See all 155 published payments
| GlaxoSmithKline | Meals · 2025-12-23 | Nucala | $22 |
| Pharming Healthcare | Meals · 2025-12-23 | Ruconest | $29 |
| ARS Pharmaceuticals Operations | Meals · 2025-12-23 | Neffy | $3 |
| ARS Pharmaceuticals Operations | Meals · 2025-12-22 | Neffy | $20 |
| CSL Behring | Meals · 2025-12-19 | Andembry | $14 |
| Amgen | Meals · 2025-12-18 | Tezspire | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-17 | Takhzyro | $23 |
| Genzyme | Meals · 2025-12-15 | Ayvakit | $36 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-12 | Tezspire | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-12-10 | Dupixent | $33 |
| Ionis Pharmaceuticals | Meals · 2025-12-05 | Dawnzera | $33 |
| Genzyme | Meals · 2025-12-04 | Dupixent | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-03 | Tezspire | $33 |
| Genentech USA | Meals · 2025-12-02 | Xolair | $38 |
| GlaxoSmithKline | Meals · 2025-12-01 | Trelegy Ellipta | $12 |
| ARS Pharmaceuticals Operations | Meals · 2025-11-25 | Neffy | $1 |
| ARS Pharmaceuticals Operations | Meals · 2025-11-24 | Neffy | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-22 | Tezspire | $27 |
| Organon | Meals · 2025-11-21 | None | $20 |
| Genzyme | Meals · 2025-11-20 | Dupixent | $15 |
| Amgen | Meals · 2025-11-13 | Tezspire | $5 |
| CSL Behring | Meals · 2025-11-13 | Andembry | $12 |
| GlaxoSmithKline | Meals · 2025-11-12 | Nucala | $20 |
| GlaxoSmithKline | Meals · 2025-11-10 | Trelegy Ellipta | $22 |
| Galderma Laboratories L.P. | Meals · 2025-11-10 | Nemluvio | $16 |
| Genzyme | Meals · 2025-11-07 | Ayvakit | $31 |
| Galderma Laboratories L.P. | Meals · 2025-11-05 | Nemluvio | $14 |
| GlaxoSmithKline | Meals · 2025-11-04 | Nucala | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-31 | Airsupra | $29 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-31 | Neffy | $17 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-31 | Neffy | $2 |
| Regeneron Healthcare Solutions | Meals · 2025-10-30 | Dupixent | $42 |
| Regeneron Healthcare Solutions | Meals · 2025-10-30 | Dupixent | $6 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-29 | Fasenra | $15 |
| Amgen | Meals · 2025-10-29 | Tezspire | $24 |
| GlaxoSmithKline | Meals · 2025-10-28 | Nucala | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Rhapsido | $29 |
| Ionis Pharmaceuticals | Meals · 2025-10-27 | Dawnzera | $17 |
| GlaxoSmithKline | Meals · 2025-10-23 | Nucala | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-10-22 | Dupixent | $32 |
| Genzyme | Meals · 2025-10-22 | Dupixent | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-20 | Rhapsido | $29 |
| LEO Pharma | Meals · 2025-10-17 | Anzupgo | $105 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Fasenra | $125 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-15 | Neffy | $29 |
| LEO Pharma | Meals · 2025-10-14 | Anzupgo | $31 |
| CSL Behring | Education · 2025-10-09 | Andembry | $60 |
| CSL Behring | Meals · 2025-10-08 | Andembry | $18 |
| Genzyme | Meals · 2025-10-02 | Dupixent | $17 |
| Ionis Pharmaceuticals | Meals · 2025-09-30 | Dawnzera | $26 |
| GlaxoSmithKline | Meals · 2025-09-29 | Trelegy Ellipta | $22 |
| GlaxoSmithKline | Meals · 2025-09-25 | Trelegy Ellipta | $9 |
| ARS Pharmaceuticals Operations | Meals · 2025-09-22 | Neffy | $29 |
| CSL Behring | Education · 2025-09-19 | Andembry | $60 |
| Grifols USA | Meals · 2025-09-19 | Xembify | $36 |
| Regeneron Healthcare Solutions | Meals · 2025-09-18 | Dupixent | $29 |
| CSL Behring | Meals · 2025-09-16 | Andembry | $24 |
| Genzyme | Meals · 2025-09-12 | Ayvakit | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-10 | Tezspire | $20 |
| ARS Pharmaceuticals Operations | Meals · 2025-09-10 | Neffy | $2 |
| ARS Pharmaceuticals Operations | Meals · 2025-09-10 | Neffy | $7 |
| ARS Pharmaceuticals Operations | Meals · 2025-09-10 | Neffy | $7 |
| Amgen | Meals · 2025-09-09 | Tezspire | $23 |
| Organon | Meals · 2025-09-09 | Vtama | $123 |
| Arcutis Biotherapeutics | Meals · 2025-09-08 | Zoryve | $26 |
| GlaxoSmithKline | Meals · 2025-09-04 | Nucala | $12 |
| BioCryst US Sales Co. | Meals · 2025-09-03 | Orladeyo | $27 |
| Pharming Healthcare | Meals · 2025-08-28 | Ruconest | $28 |
| Hikma Pharmaceuticals USA | Meals · 2025-08-22 | Ryaltris | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Tezspire | $20 |
| Amgen | Meals · 2025-08-15 | Tezspire | $22 |
| ARS Pharmaceuticals Operations | Meals · 2025-08-11 | Neffy | $8 |
| CSL Behring | Meals · 2025-08-09 | Andembry | $8 |
| Amgen | Education · 2025-08-06 | None | $34 |
| Genzyme | Meals · 2025-08-06 | Ayvakit | $35 |
| GlaxoSmithKline | Meals · 2025-08-05 | Nucala | $28 |
| Optinose US | Meals · 2025-07-20 | Xhance | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-18 | Cuvitru | $22 |
| Genzyme | Meals · 2025-07-16 | Dupixent | $37 |
| Lilly USA | Meals · 2025-07-15 | Ebglyss | $20 |
| Blueprint Medicines | Meals · 2025-07-09 | Ayvakit | $39 |
| CSL Behring | Meals · 2025-07-08 | Andembry | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-02 | Airsupra | $23 |
| ARS Pharmaceuticals Operations | Meals · 2025-07-02 | Neffy | $14 |
| GlaxoSmithKline | Meals · 2025-06-25 | Nucala | $29 |
| Pharming Healthcare | Meals · 2025-06-24 | Ruconest | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-20 | Tezspire | $34 |
| Genzyme | Meals · 2025-06-18 | Dupixent | $35 |
| Amgen | Meals · 2025-06-17 | Tezspire | $26 |
| ARS Pharmaceuticals Operations | Meals · 2025-06-17 | Neffy | $10 |
| Lilly USA | Meals · 2025-06-12 | Ebglyss | $16 |
| GlaxoSmithKline | Meals · 2025-06-12 | Trelegy Ellipta | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-06-12 | Dupixent | $30 |
| GlaxoSmithKline | Meals · 2025-06-11 | Nucala | $8 |
| Kowa Pharmaceuticals America | Meals · 2025-06-04 | Zoryve | $24 |
| Genzyme | Meals · 2025-06-03 | Dupixent | $46 |
| GlaxoSmithKline | Meals · 2025-05-30 | Trelegy Ellipta | $20 |
| GlaxoSmithKline | Meals · 2025-05-28 | Nucala | $19 |
| GlaxoSmithKline | Meals · 2025-05-21 | Nucala | $25 |
| Amgen | Meals · 2025-05-21 | Tezspire | $17 |
| Genzyme | Meals · 2025-05-21 | Dupixent | $36 |
| GlaxoSmithKline | Meals · 2025-05-15 | Nucala | $10 |
| Pharming Healthcare | Meals · 2025-05-15 | Ruconest | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-13 | Tezspire | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-12 | Cuvitru | $30 |
| CSL Behring | Meals · 2025-05-10 | Haegarda | $11 |
| Genzyme | Meals · 2025-05-08 | Dupixent | $14 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Xolair | $31 |
| Novartis Pharmaceuticals | Meals · 2025-05-06 | None | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Airsupra | $35 |
| ARS Pharmaceuticals Operations | Meals · 2025-05-05 | Neffy | $9 |
| Kowa Pharmaceuticals America | Meals · 2025-05-03 | Zoryve | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-05-01 | Dupixent | $29 |
| GlaxoSmithKline | Meals · 2025-04-28 | Trelegy Ellipta | $2 |
| GlaxoSmithKline | Meals · 2025-04-28 | Trelegy Ellipta | $9 |
| Galderma Laboratories L.P. | Meals · 2025-04-23 | Nemluvio | $35 |
| Novartis Pharmaceuticals | Meals · 2025-04-18 | None | $26 |
| CSL Behring | Education · 2025-04-17 | Haegarda | $60 |
| GlaxoSmithKline | Meals · 2025-04-16 | Nucala | $29 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-14 | Neffy | $3 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-14 | Neffy | $9 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-14 | Neffy | $9 |
| Optinose US | Meals · 2025-04-11 | Xhance | $20 |
| Genzyme | Meals · 2025-04-09 | Dupixent | $24 |
| GlaxoSmithKline | Meals · 2025-04-02 | Trelegy Ellipta | $11 |
| Grifols USA | Meals · 2025-03-29 | Xembify | $35 |
| CSL Behring | Meals · 2025-03-26 | Haegarda | $19 |
| BioCryst US Sales Co. | Meals · 2025-03-19 | Orladeyo | $24 |
| GlaxoSmithKline | Meals · 2025-03-13 | Nucala | $121 |
| Genzyme | Meals · 2025-03-13 | Dupixent | $12 |
| ARS Pharmaceuticals Operations | Meals · 2025-03-13 | Neffy | $28 |
| GlaxoSmithKline | Meals · 2025-03-11 | Nucala | $32 |
| GlaxoSmithKline | Meals · 2025-03-06 | Nucala | $10 |
| GlaxoSmithKline | Meals · 2025-03-04 | Nucala | $33 |
| Blueprint Medicines | Meals · 2025-02-28 | Ayvakit | $50 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-24 | Cuvitru | $27 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-24 | Neffy | $1 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-24 | Neffy | $7 |
| Viatris Specialty | Meals · 2025-02-21 | Yupelri | $28 |
| GlaxoSmithKline | Meals · 2025-02-20 | Trelegy Ellipta | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-13 | Tezspire | $26 |
| Genentech USA | Meals · 2025-02-12 | Xolair | $23 |
| GlaxoSmithKline | Meals · 2025-02-11 | Nucala | $19 |
| GlaxoSmithKline | Meals · 2025-02-11 | Nucala | $16 |
| GlaxoSmithKline | Meals · 2025-02-05 | Nucala | $32 |
| GlaxoSmithKline | Meals · 2025-02-05 | Nucala | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-28 | Airsupra | $20 |
| ARS Pharmaceuticals Operations | Meals · 2025-01-27 | Neffy | $1 |
| ARS Pharmaceuticals Operations | Meals · 2025-01-26 | Neffy | $7 |
| GlaxoSmithKline | Meals · 2025-01-23 | Trelegy Ellipta | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-01-23 | Dupixent | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-13 | Cuvitru | $32 |
| CSL Behring | Meals · 2025-01-11 | Haegarda | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-09 | Fasenra | $263 |
| Amgen | Meals · 2025-01-08 | Tezspire | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,159
| AstraZeneca Pharmaceuticals LP | Tezspire | $582 | 14 payments
|
| GlaxoSmithKline | Nucala | $167 | 10 payments
|
| Genzyme | Dupixent | $161 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $140 | 5 payments
|
| CSL Behring | Hizentra | $132 | 5 payments
|
| Mylan Specialty L.P. | Yupelri | $109 | 4 payments
|
| Pharming Healthcare | Ruconest | $109 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $96 | 3 payments
|
| Genentech USA | Xolair | $83 | 4 payments
|
| Optinose US | Xhance | $70 | 3 payments
|
| Grifols USA | Xembify | $63 | 3 payments
|
| kaleo | Auvi-Q | $56 | 2 payments
|
| Pfizer | Octagam Immune Globulin (Human) | $53 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $51 | 2 payments
|
| Octapharma USA | Cutaquig | $48 | 2 payments
|
| Hikma Pharmaceuticals USA | Ryaltris | $46 | 2 payments
|
| Greer Laboratories | Oralair | $44 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $40 | 2 payments
|
| LEO Pharma | Adbry | $31 | 1 payment
|
| Amgen | Tezspire | $29 | 1 payment
|
| Hospira | Panzyga | $28 | 1 payment
|
| Phadia US | Immunocap | $20 | 1 payment
|
2023: $2,809
| AstraZeneca Pharmaceuticals LP | Fasenra | $825 | 14 payments
|
| GlaxoSmithKline | Nucala | $598 | 22 payments
|
| Genzyme | Dupixent | $451 | 15 payments
|
| Amgen | Tezspire | $200 | 9 payments
|
| Mylan Specialty L.P. | Yupelri | $126 | 4 payments
|
| Novartis Pharmaceuticals | Xolair | $109 | 4 payments
|
| CSL Behring | Hizentra | $66 | 3 payments
|
| ALK-Abello | Odactra | $60 | 2 payments
|
| Greer Laboratories | Oralair | $57 | 2 payments
|
| Octapharma USA | Cutaquig | $54 | 2 payments
|
| Optinose US | Xhance | $48 | 2 payments
|
| Hikma Pharmaceuticals USA | Ryaltris | $47 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $47 | 2 payments
|
| Pfizer | Eucrisa | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $27 | 1 payment
|
| LEO Pharma | Adbry | $24 | 1 payment
|
| Genentech USA | Xolair | $24 | 1 payment
|
| Grifols USA | Xembify | $19 | 1 payment
|
2022: $2,366
| GlaxoSmithKline | Trelegy Ellipta | $391 | 23 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $355 | 11 payments
|
| CSL Behring | Haegarda | $318 | 14 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $262 | 12 payments
|
| Genzyme | Dupixent | $255 | 11 payments
|
| Amgen | Tezspire | $123 | 6 payments
|
| Pfizer | Eucrisa | $90 | 4 payments
|
| ALK-Abello | Odactra | $66 | 3 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $64 | 3 payments
|
| Incyte | Opzelura | $56 | 2 payments
|
| Covis Pharma GmBH | Alvesco | $53 | 2 payments
|
| Genentech USA | Xolair | $52 | 3 payments
|
| Mylan Specialty L.P. | Yupelri | $51 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $43 | 2 payments
|
| LEO Pharma | Adbry | $30 | 2 payments
|
| Greer Laboratories | Oralair | $29 | 1 payment
|
| Hospira | Cutaquig | $27 | 1 payment
|
| OptiNose US | Xhance | $23 | 1 payment
|
| Ethicon US | None | $23 | 1 payment
|
| kaleo | Auvi-Q | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $20 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $13 | 1 payment
|
2021: $2,118
| GlaxoSmithKline | Nucala | $421 | 26 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $287 | 12 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $199 | 9 payments
|
| CSL Behring | Haegarda | $170 | 14 payments
|
| Pfizer | Eucrisa | $139 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $124 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $99 | 4 payments
|
| ALK-Abello | Odactra | $98 | 4 payments
|
| Genentech USA | Xolair | $66 | 3 payments
|
| kaleo | Auvi-Q | $64 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $57 | 3 payments
|
| Covis Pharma GmBH | Alvesco | $56 | 2 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $53 | 2 payments
|
| Grifols USA | Xembify | $46 | 2 payments
|
| Genzyme | Dupixent | $33 | 2 payments
|
| Amgen | None | $31 | 1 payment
|
| Incyte | Opzelura | $29 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $26 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $25 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $24 | 1 payment
|
| Optinose US | Xhance | $22 | 1 payment
|
| Uswm | Symjepi | $21 | 1 payment
|
| Merck Sharp & Dohme | None | $15 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $13 | 1 payment
|
2020: $1,735
| GlaxoSmithKline | Nucala | $473 | 29 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $236 | 11 payments
|
| Pfizer | Eucrisa | $173 | 8 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $158 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $151 | 7 payments
|
| CSL Behring | Haegarda | $145 | 8 payments
|
| Genzyme | Dupixent | $102 | 5 payments
|
| ALK-Abello | Odactra | $50 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $40 | 2 payments
|
| Genentech USA | Xolair | $39 | 2 payments
|
| Covis Pharma GmbH | Alvesco | $33 | 1 payment
|
| Sanofi-Aventis U.S. | None | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $26 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $23 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $19 | 1 payment
|
| BioCryst Pharmaceuticals | Orladeyo | $18 | 1 payment
|
| Greer Laboratories | Oralair | $18 | 1 payment
|
2019: $1,698
| Regeneron Healthcare Solutions | Dupixent | $257 | 8 payments
|
| GlaxoSmithKline | Nucala | $193 | 10 payments
|
| Shire North American Group | Takhzyro | $160 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $139 | 6 payments
|
| Octapharma USA | Cutaquig | $131 | 1 payment
|
| Pfizer | Eucrisa | $127 | 9 payments
|
| Greer Laboratories | Oralair | $119 | 5 payments
|
| Novartis Pharmaceuticals | Xolair | $92 | 4 payments
|
| OptiNose US | Xhance | $74 | 4 payments
|
| Teva Pharmaceuticals USA | Cinqair | $66 | 2 payments
|
| Genzyme | Dupixent | $66 | 3 payments
|
| CSL Behring | Haegarda | $51 | 3 payments
|
| Kaleo | Auvi-Q | $33 | 2 payments
|
| Covis Pharma B.V. | Alvesco | $28 | 1 payment
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $23 | 1 payment
|
| Genentech USA | Xolair | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $23 | 1 payment
|
| Pharming Healthcare | Ruconest | $20 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $20 | 1 payment
|
| Circassia Pharmaceuticals | Niox Vero | $20 | 1 payment
|
| Grifols USA | Xembify | $18 | 1 payment
|
| ALK-Abello | Odactra | $17 | 1 payment
|
Professional record
- NPI
- 1932149697
- Licence
- CA A54166California A54166: Current · expires 2027-05-31
- Trained
- Tulane University School of Medicine, 1993
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207KA0200X (207KA0200X)
- Mailing address
- 130 Bellerose Dr, San Jose, CA, 95128
- NPI first listed
- 2006-06-08
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.